X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 55 filers reported holding X4 PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,592,702 | -39.8% | 2,378,626 | +7.2% | 0.00% | – |
Q2 2023 | $4,305,991 | +2800.6% | 2,219,583 | +1200.8% | 0.00% | – |
Q1 2023 | $148,451 | -56.2% | 170,633 | -50.0% | 0.00% | – |
Q4 2022 | $338,878 | +260.5% | 341,266 | +523.5% | 0.00% | – |
Q3 2022 | $94,000 | +77.4% | 54,733 | 0.0% | 0.00% | – |
Q2 2022 | $53,000 | -44.8% | 54,733 | 0.0% | 0.00% | – |
Q1 2022 | $96,000 | -13.5% | 54,733 | +12.9% | 0.00% | – |
Q4 2021 | $111,000 | -56.6% | 48,480 | 0.0% | 0.00% | – |
Q3 2021 | $256,000 | -18.7% | 48,480 | 0.0% | 0.00% | – |
Q2 2021 | $315,000 | -86.8% | 48,480 | -82.5% | 0.00% | – |
Q1 2021 | $2,384,000 | -9.6% | 276,840 | -32.5% | 0.00% | – |
Q4 2020 | $2,636,000 | -8.0% | 409,910 | -3.1% | 0.00% | – |
Q3 2020 | $2,864,000 | -26.9% | 423,086 | +0.7% | 0.00% | – |
Q2 2020 | $3,917,000 | +42.4% | 420,286 | +52.9% | 0.00% | – |
Q1 2020 | $2,750,000 | +47.1% | 274,955 | +57.4% | 0.00% | – |
Q4 2019 | $1,869,000 | +3.5% | 174,664 | +23.0% | 0.00% | – |
Q3 2019 | $1,805,000 | +48.7% | 142,007 | +75.5% | 0.00% | – |
Q2 2019 | $1,214,000 | +294.2% | 80,926 | +357.4% | 0.00% | – |
Q1 2019 | $308,000 | – | 17,692 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 1,717,589 | $3,006,000 | 1.17% |
SV Health Investors, LLC | 311,490 | $545,000 | 0.66% |
Bain Capital Life Sciences Investors, LLC | 3,019,540 | $5,284,000 | 0.51% |
AIGH Capital Management LLC | 997,719 | $1,746,000 | 0.43% |
Ikarian Capital, LLC | 1,372,022 | $2,402,000 | 0.32% |
New Leaf Venture Partners, L.L.C. | 335,000 | $586,000 | 0.29% |
Worth Venture Partners, LLC | 250,144 | $438,000 | 0.20% |
Sio Capital Management, LLC | 276,909 | $485,000 | 0.16% |
BVF INC/IL | 847,879 | $1,484,000 | 0.06% |
Orbimed Advisors | 1,373,849 | $2,404,000 | 0.04% |